Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKinsey
Cantor Fitzgerald
Federal Trade Commission
Daiichi Sankyo
Queensland Health
Deloitte
Farmers Insurance
Fish and Richardson

Generated: July 21, 2018

DrugPatentWatch Database Preview

Vecuronium bromide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for vecuronium bromide and what is the scope of vecuronium bromide freedom to operate?

Vecuronium bromide
is the generic ingredient in two branded drugs marketed by Organon Usa Inc, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sagent Pharms, Sun Pharma Global, Teva Pharms Usa, Watson Labs, and West-ward Pharms Int, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for vecuronium bromide. Eight suppliers are listed for this compound.
Pharmacology for vecuronium bromide
Medical Subject Heading (MeSH) Categories for vecuronium bromide
Synonyms for vecuronium bromide
(+)-1-(3,17-diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide
(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane bromide
(2beta,3alpha,5alpha,16beta,17beta)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane bromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide
1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium bromide
1-(3,17-Diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide
1-(3alpha,17beta-Dihydroxy-2beta-piperidino-5alpha-androstan-16beta,5alpha-yl)-1-methylpiperidinium bromide, diacetate
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(piperidin-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium bromide
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(piperidin-1-yl)tetracyclo[8.7.0.0?,?.0??,??]heptadecan-13-yl]-1-methylpiperidin-1-ium bromide
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-BIS(ACETYLOXY)-2,15-DIMETHYL-4-(PIPERIDIN-1-YL)TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECAN-13-YL]-1-METHYLPIPERIDIN-1-IUM BROMIDE
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(piperidin-1-yl)tetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadecan-13-yl]-1-methylpiperidin-1-ium bromide
1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methyl-piperidinium bromide
1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide
1-[3alpha,17beta-bis(acetoxy)-2beta-(1-piperidinyl)-5alpha-androstan-16beta-yl]-1-methylpiperidinium bromide
50700-72-6
50700-72-6,86029-43-8(freebase),74531-76-3(Maleicacid)
5alpha-Androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate
63884-29-7
72254-12-7
74531-67-2
7E4PHP5N1D
AB0013312
AB2000091
AC-2000
AC1L22EC
acetate;bromide
AK-35374
AKOS005145904
AKOS007930694
Ambap158966-92-8
AN-6972
BC201778
Bromure de vecuronium
Bromure de vecuronium [INN-French]
Bromuro de vecuronio
Bromuro de vecuronio [INN-Spanish]
C34H57N2O4
C34H57N2O4.Br
CAS-50700-72-6
CCG-101147
CHEBI:9940
CHEMBL1200629
CS-1881
D00767
DSSTox_CID_3736
DSSTox_GSID_23736
DSSTox_RID_77174
DTXSID1023736
EINECS 256-723-9
H858
HMS2052I21
HY-B0118A
LS-116453
MCULE-7004468628
MFCD00867762
MLS001424317
MolPort-005-932-826
NC-45
NC00397
NCGC00167467-01
NCGC00167467-03
NE47510
Norcuron
Norcuron (TN)
Norcuron;Org NC 45
ORG NC 45
ORG-NC 45
Org-NC-45
ORG-NC45
Piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, bromide
Piperidinium, 1-(3-alpha,17-beta-diacetoxy-2-beta-piperidino-5-alpha-androstan-16-beta-yl)-1-methyl-, bromide
PL000463
Q-101014
S1405
SCHEMBL22250
SMR000471625
ST24050344
Tox21_112471
Tox21_112471_1
UNII-7E4PHP5N1D
vecronium bromide
Vecuronii bromidum
Vecuronii bromidum [INN-Latin]
Vecuronium (bromide)
Vecuronium bromide (JAN/USAN/INN)
Vecuronium bromide [USAN:BAN:INN:JAN]
Vecuronium bromide [USAN:USP:INN:BAN:JAN]
Vecuronium bromide, European Pharmacopoeia (EP) Reference Standard
Vecuronium Bromide, pharmaceutical secondary standard; traceable to USP, PhEur
Vecuronium bromide, United States Pharmacopeia (USP) Reference Standard
Vecuronium for peak identification, European Pharmacopoeia (EP) Reference Standard
Vecuronium for system suitability, European Pharmacopoeia (EP) Reference Standard
Vecuronium Hydrobromide
Z1551429734

US Patents and Regulatory Information for vecuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-003 Jan 3, 1992 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 075218-001 Aug 23, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 079001-001 Jun 17, 2009 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 090243-001 May 11, 2010 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for vecuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-003 Jan 3, 1992 ➤ Sign Up ➤ Sign Up
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-003 Jan 3, 1992 ➤ Sign Up ➤ Sign Up
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984 ➤ Sign Up ➤ Sign Up
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cerilliant
Farmers Insurance
Citi
Chubb
Cipla
Moodys
QuintilesIMS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.